NC Soft ( KS / KS)

Size: px
Start display at page:

Download "NC Soft ( KS / KS)"

Transcription

1 20 uary 2011 Asia Pacific/South Korea Equity Research Internet Infrastructure Services Rating OUTPERFORM* [V] Price (19 11, W) 201, Target price (W) 330,000¹ Chg to TP (%) 64.2 Market cap. (W bn) 4, (US$ 3.94) Enterprise value (W bn) 3,927 Number of shares (mn) Free float (%) week price range *Stock ratings are relative to the relevant country benchmark. ¹Target price is for 12 months. [V] = Stock considered volatile (see Disclosure Appendix). Share price performance Price (LHS) Research Analysts Jeff Kahng jeff.kahng@credit-suisse.com Jihong Choi jihong.choi@credit-suisse.com Rebased Rel (RHS) -09 May-09 Sep May-10 Sep-10 The price relative chart measures performance against the KOREA SE COMPOSITE (KOSPI) index which closed at on 19/01/11 On 19/01/11 the spot exchange rate was W /US$ Performance Over 1M 3M 12M Absolute (%) Relative (%) ( KS / KS) COMPANY UPDATE March CBT of B&S to fuel share performance Poor performance in past one month. After the stock hit an all-time high of W273,000 following the November game show in Busan, NCsoft fell 26% in two months on: (1) potential delays in the commercial launch of Blade & Soul (B&S) and Guild Wars 2 (GW2) to 2012 or even to 2013, and (2) the negative impact from NHN s Tera launch. We, however, believe the market concerns are overdone. In particular, with a firm plan to launch B&S in 2H11, we expect NCsoft to start the first round of close beta testing (CBT) for B&S in March and start reversing the negative sentiments around the stock. Expect flattish 2011 but solid Although we remain confident about the commercial launch of B&S and GW2 in 2H11, we push our assumption on the product launch schedule back by one quarter (from 3Q11 to 4Q11) for B&S in Korea and GW2 in the US/EU. Thus, along with more conservative assumptions on item sales for Lineage 2 (L2), we cut our 2011E revenue by 14.8% to W826 bn, operating profit by 24.8% to W279 bn, and net profit by 23.9% to W223 bn. However, with most of the new products revenue impact fully reflected in 2012, we make virtually no changes to our 2012E revenue and profit. Based on our earnings adjustments, we now expect E EPS growth to reach 14.2% and 64.9%, respectively. Catalysts. Key catalysts for NCsoft include: (1) announcement of B&S CBT in March (possibly during the February 4Q10 earnings announcement), (2) announcement of China publishing B&S in mid-2011 and (3) resilient earnings, despite the full commercial launch of Tera. Maintain target price at W330,000. Despite downgrading our 2011E earnings significantly, we maintain our 12-month target price of W330,000 based on the same 2012E P/E of 18x. Given NCsoft s share price movement is driven largely by new product launch, we believe 2012E earnings are more reflective of its fundamentals and earnings outlook. Financial and valuation metrics Year 12/09A 12/10E 12/11E 12/12E Revenue (W bn) EBITDA (W bn) EBIT (W bn) Net income (W bn) EPS (CS adj.) (W) 9, , , , Change from previous EPS (%) n.a Consensus EPS (W) n.a. 9,039 12,846 17,413 EPS growth (%) P/E (x) Dividend yield (%) P/B (x) ROE Net debt/equity (%) net cash net cash net cash net cash Source: Company data, Thomson Reuters, Credit Suisse estimates. DISCLOSURE APPENDIX CONTAINS ANALYST CERTIFICATIONS AND THE STATUS OF NON-US ANALYSTS. U.S. Disclosure: Credit Suisse does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.

2 20 uary 2011 Focus tables Figure 1: NCSoft E earnings revision New CS est. Old CS est. Change W bn 2010E 2011E 2012E 2010E 2011E 2012E 2010E 2011E 2012E Revenue % -15% 0% (1) Subscription % -13% 0% L % -1% -1% L % -10% -10% Aion % -1% -1% B&S n.a. -68% 19% GW % -32% -32% Others % -1% 0% (2) Royalty % -34% 0% Lineage % 0% 0% Lineage % 0% 1% Aion % 0% 0% Blade & Soul n.a. n.a. 0% Others % 0% 0% Operating profit % -25% -1% Pre-tax profit % -24% -1% Net profit % -24% -1% EPS (W) 9,408 10,743 17,718 9,576 14,122 17,915-2% -24% -1% Operating margin 40.3% 39.7% 48.6% 40.5% 44.9% 49.3% Source: Credit Suisse estimates Figure 2: CS estimates versus consensus 4Q10E 2010E 2011E 2012E W bn CS Cons CS Cons CS Cons CS Cons Revenue Operating profit Pre-tax profit Net profit Operating margin 37.2% 42.1% 40.3% 42.0% 39.7% 43.8% 48.6% 50.9% Source: Credit Suisse estimates, Bloomberg Figure 3: Valuation comparison Company Ticker CS Price EPS grth (%) P/E (x) 10E ROE 10E P/B Rating Local Target 11E 12E 11E 12E (%) (x) NCsoft KS O 201, , Neowiz Games KS O 43,550 75, NHN KS N 199, , Daum KS O 80,100 99, Source: Company data, Credit Suisse estimates Figure 4: Game room market share by playing hours uary 2011 daily game room market share 2010 daily market share by month J-10 F-10 M-10 A-10 M-10 J-10 J-10 A-10 S-10 O-10 N-10 D-10 Aion L L Tera Source: Gametrics ( KS / KS) 2

3 20 uary 2011 Earnings adjustments for E Downward earnings adjustments Due to changes to our basic assumptions on new product launch as well as its business models, we cut our 2011E revenue by 14.8% to W826 bn, operating profit by 24.8% to W279 bn, and net profit by 23.9% to W223 bn, driven largely by our assumption of one quarter delay (from 3Q11 to 4Q11) for the B&S as well as GW2 launch. However, with most of the new products revenue impact fully reflected in 2012, we make virtually no changes to our 2012E revenue and profit. Figure 5: Earnings revision E New CS est. Old CS est. change W bn 2010E 2011E 2012E 2010E 2011E 2012E 2010E 2011E 2012E Revenue % -14.8% 0.2% (1) Korea subs % -9.6% 2.1% Lineage % -1.4% -1.4% Lineage % -16.5% -16.5% Aion % -1.0% -1.0% Blade & Soul n.a. n.a. 25.0% Others % -0.4% -0.3% (2) Overseas subs % -19.6% -3.0% Lineage % -0.1% -0.1% Lineage % 0.5% 0.5% CoH/CoV % -0.1% 0.3% Guild Wars % -31.8% -31.8% Aion % 0.0% 0.0% Blade & Soul n.a. n.a. 10.9% Others % -1.7% 0.0% (3) Royalty % -33.8% 0.0% Lineage % 0.2% 0.2% Lineage % -0.2% 0.5% Aion % 0.0% 0.2% Blade & Soul n.a. n.a. 0.0% Others % 0.0% 0.0% Operating profit % -24.8% -1.1% Pre-tax profit % -23.9% -1.1% Net profit % -23.9% -1.1% EPS (W) 9,408 10,743 17,718 9,576 14,122 17, % -23.9% -1.1% Operating margin 40.25% 39.67% 48.61% 40.54% 44.95% 49.27% Source: Company data, Credit Suisse estimates Figure 6: CS estimates versus consensus 4Q10E 2010E 2011E 2012E W bn CS Cons CS Cons CS Cons CS Cons Revenue Operating profit Pre-tax profit Net profit Operating margin 37.2% 42.1% 40.3% 42.0% 39.7% 43.8% 48.6% 50.9% Source: Credit Suisse estimates, Bloomberg ( KS / KS) 3

4 20 uary 2011 Key revenue assumptions Launch date for Blade & Soul With a firm plan to commercially launch B&S in 2H11, NCsoft is preparing to the announce CBT date. Although no specific dates have been set, we expect NCsoft to begin the first round of CBT in March 2011, following an announcement in mid-february. If all goes well, it is still possible for NCsoft to complete the second round of CBT and 2-3 weeks of OBT by end-jul. In such a case, the company could begin its commercial service by Aug However, it seems increasingly likely for NCsoft to take a slightly longer testing period for B&S. Even if there isn t any technology glitches, NCsoft may still launch B&S at the start of 2011/2012 winter season purely due to marketing reasons. With winter season typically generating higher interest and usage for online games, NCsoft had conducted Aion OBT in Nov and went commercial in Dec Thus, rather than our previous assumption for a 3Q11 launch for B&S, we now push our B&S launch assumption back to 4Q11, more specifically to Dec 2011, for Korea. For overseas markets, we assume 2Q12 launch for China, Japan and Taiwan, and 3Q12 launch for North America and Europe. Launch assumption for Guild War 2 Although the market has paid less attention to GW2 versus B&S, the launch of GW2 is an important event for NCsoft from the perspective of its North American and European expansion strategy. After its demo version received a number of key awards in game shows across Europe and the US in the past six months, GW2 has potential to become a blockbuster game for NCsoft s US/EU product line. It is widely speculated that GW2 is less prepared to enter beta testing than B&S, with the company yet to release any firm launch schedule. However, we understand Arenanet, the developer of GW2 and a 100%-owned subsidy of NCsoft, is still targeting 2011 Christmas season launch. Thus, despite less certainty over the GW2 launch in 2011 compared to that of B&S, we assume a 4Q11 launch (versus 3Q11 previously) for GW2 in North America and Europe, with no launch assumptions for Asia. Downward adjustments for existing titles For existing titles, we make downward adjustments to E revenue based on the following factors. Although we are confident that NHN s Tera launch will have a minimal impact on NCsoft s existing titles, we cut our domestic E revenue for L2 by 16.5%, due largely to our more conservative assumptions on item sales. Impact of Tera. With NHN s Tera still on OBT (commercial launch will begin on 25 at the same monthly price of W19,800 to that of Aion), it is difficult to gauge the full impact of Tera on NHN s existing titles. Simply looking at the game room market share data, NCsoft s top titles have mostly maintained their market share, despite a slight dip in market share. Given the company has maintained similar levels of revenue during 3Q10 versus previous quarters when the World Cup fever brought down their market share, we remain confident that NCsoft s existing titles will maintain their current stream of revenue in Slow adoption of item sales. Following the successful launch of item sales for L1 in 2010, NCsoft has failed to replicate the success of L1 to L2 and Aion. However, besides L1, the results were rather disappointing, with a minimal revenue impact from item sales. Although the company is looking to introduce more aggressive measures, including opening of in-game stores and structural changes to facilitate item sales, we cross out our assumptions for E related to additional revenue from item sales. ( KS / KS) 4

5 20 uary 2011 Figure 7: Game room market share by playing hours uary 2011 daily game room market share 2010 daily market share by month J-10 F-10 M-10 A-10 M-10 J-10 J-10 A-10 S-10 O-10 N-10 D-10 Aion L L Tera Source: Gametrics Figure 8: Share price vs OBT/commercial launch 300,000 (W) 250,000 Tabula launch Nov ,000 GW OBT Apr 05 GW launch May 05 Tabula CBT May 07 Tabula OBT Oct , ,000 Lineage 2 CBT Oct 02 Lineage 2 launch Oct 03 Lineage 2 OBT Jul 03 CoH OBT 06 CoH CBT Aug 05 CoH launch Mar 06 Aion 1st CBT Oct 07 Aion OBT Nov 08 Aion lanuch Nov 08 50,000 - Jul-00 Oct Apr-01 Jul-01 Oct Apr-02 Jul-02 Oct Apr-03 Jul-03 Oct Apr-04 Jul-04 Oct Apr-05 Jul-05 Oct Apr-06 Jul-06 Oct Apr-07 Jul-07 Oct Apr-08 Jul-08 Oct Apr-09 Jul-09 Oct Apr-10 Jul-10 Oct NCSoft share price Source: Datastream, Company data Figure 9: Quarterly earnings estimates W bn 1Q10 2Q10 3Q10 4Q10E 1Q11E 2Q11E 3Q11E 4Q11E Revenue (1) Subscription L L Aion B&S GW Others (2) Royalty L L Aion B&S Others Operating profit Pre-tax profit Net profit Operating margin 45.8% 42.2% 35.4% 37.2% 46.0% 44.0% 43.0% 29.5% Source: Company data, Credit Suisse estimates ( KS / KS) 5

6 20 uary 2011 Target price and valuations Despite downgrading our 2011E earnings significantly, we maintain our 12-month target price of W330,000 due to our target P/E 2012E. We believe using 2012E P/E target is appropriate, as NCsoft s share price movement is largely driven by new product launch that would have full-year impact only in 2012 rather than in In fact, when comparing one-year as well as two-year forward P/E charts, we see less volatility in two-year forward P/E charts than that in one-year forward P/E charts, which indicates NCsoft s share price performance is driven more by longer-term earnings outlook. In terms of DCF valuations, we see a slight decline in the company s value, due mostly to our 2011E earnings downgrade. That said, the decline for 2011E is not significant enough to cause a major drop in its share price or hurt earnings momentum for 2012 and beyond. Figure 10: Valuation comparison Company Ticker CS Price EPS grth (%) P/E (x) 10E ROE 10E P/B Rating Local Target 11E 12E 11E 12E (%) (x) NCsoft KS O 201, , Neowiz Games KS O 43,550 75, NHN KS N 199, , Daum KS O 80,100 99, Source: Company data, Credit Suisse estimates Figure 11: DCF valuation summary Based on current est. Based on previous est. DCF value (W) 339, ,386 Current share price (W) 201, ,000 % upside 68.7% 70.8% WACC 9.0% 9.0% Cost of debt 5.5% 5.5% Cost of equity 9.0% 9.0% Implied terminal growth rate 4.0% 4.0% Source: Credit Suisse estimates Figure 12: NCsoft s one-year versus two-year forward P/E (X) -06 May-06 Sep May-07 Sep May-08 Sep May-09 Sep May-10 Sep yr fwd PE 2yr fwd PE Source: Datastream, Credit Suisse estimates ( KS / KS) 6

7 20 uary 2011 Summary financials Figure 13: Income statement Year to Dec. (W bn) E 2011E 2012E Sales % YoY -2.6% 5.2% 83.0% 3.7% 6.9% 41.1% (1) Subscription revenue Lineage Lineage City of Heroes Guild Wars Aion Others (2) Overseas royalty Lineage Lineage Aion Others Operating costs (280.2) (296.8) (400.7) (393.3) (424.7) (510.4) % YoY -5.1% 5.9% 35.0% -1.9% 8.0% 20.2% Labour (138.4) (154.9) (198.7) (209.8) (228.0) (249.0) Depreciation & amortisation (20.6) (22.0) (26.6) (25.7) (26.6) (36.4) Commission paid (27.3) (26.6) (40.4) (36.1) (41.6) (53.3) Marketing commission (5.9) (5.8) (13.7) (0.8) (0.7) (0.9) Advertising (16.7) (11.8) (17.5) (14.3) (16.4) (26.3) Others (71.3) (75.7) (103.7) (106.7) (111.4) (144.5) Operating income % YoY 14.3% 1.2% 367.5% 13.2% 5.4% 72.9% Operating margin 19.7% 21.0% 36.9% 40.3% 39.7% 48.6% EBITDA % YoY 7.0% 2.9% 261.5% 11.5% 5.2% 69.8% EBITDA margin 21.2% 20.8% 41.1% 44.2% 43.4% 52.3% Non-operating items 12.6 (9.0) 6.7 (16.0) Interest Income Interest Expense (0.0) (0.1) (0.0) (0.1) (0.1) (0.1) Net FX (2.7) Donation (0.2) (0.3) (0.2) (0.7) (0.7) (1.0) Gain(loss) from Equity methods (2.3) (13.7) (1.8) (4.6) (0.4) 0.2 Others (0.4) (13.1) (3.3) (30.0) (5.0) (5.0) Pre-tax profit % YoY 24.2% -34.0% 486.9% 3.4% 17.4% 69.7% Pre-tax margin 18.8% 11.8% 37.9% 37.8% 41.5% 50.0% Income Taxes (16.2) (13.3) (52.4) (54.8) (68.7) (124.1) Effective Tax Rate 26.0% 32.5% 21.8% 22.0% 23.5% 25.0% Minority interests (0.9) (2.0) (4.1) (3.0) (3.2) (5.0) Consolidated net income % YoY 18.4% -43.1% 618.7% 3.8% 15.3% 66.5% Net margin 13.7% 7.4% 29.0% 29.0% 31.3% 37.0% EPS (W) 2,197 1,248 9,155 9,408 10,743 17,718 Source: Company data, Credit Suisse estimates ( KS / KS) 7

8 20 uary 2011 Figure 14: Balance sheet Year to Dec. (W bn) E 2011E 2012E Current assets Cash and cash equivalent Marketable securities Acct. receivable Short-term loans Inventory Other current assets Total current assets Fixed Assets Long-term investments Investments Long-term loans Net PP&E Intangibles Deferred assets Total fixed assets ,004.4 Total assets , , ,641.8 Current liabilities Acct. payable ST borrowings Current portion of LT Debt Accrued expenses Other current liabilities Total current liabilities Long-term liabilities Long-term debt Allowances for liabilities Other LT liabilities Total LT liabilities Total liabilities Shareholder equity Paid-in capital Capital surplus Retained earnings ,263.7 Capital adjustment (50.6) (88.0) (100.1) (100.1) (100.1) (100.1) Total shareholder equity , ,384.7 Total liabilities & SH equity , , ,641.8 Source: Company data, Credit Suisse estimates ( KS / KS) 8

9 20 uary 2011 Figure 15: Cash flow statement Year to Dec. (W bn) E 2011E 2012E Cash flow from operations Net income Dep'n/Amortisation Equity Method Valuation Loss (Gain) (0.2) Stock Option Compensation Other non-cash items Change in working capital (2.1) 3.9 (29.5) (3.7) (4.9) (30.5) Net operating cash flow Cash flow from investment Capex (26.4) (27.7) (38.1) (32.9) (31.7) (44.7) Disposal of PP&E Other investment (net) (28.7) 10.5 (160.7) (190.9) (212.3) (328.4) Net investment cash flow (55.0) (17.2) (198.7) (223.8) (243.9) (373.0) Cash flow from financing Dividend paid 0.0 (19.1) (8.7) (9.8) (14.9) (20.1) Change in share capital (19.3) (37.2) Change in interest-bearing debt Other financing Net financing cash flow (19.3) (56.3) 35.5 (7.7) (12.9) (18.1) Cash equiv. (begin) Cash equiv. (end) Net change in cash Source: Company data, Credit Suisse estimates ( KS / KS) 9

10 20 uary 2011 Companies Mentioned (Price as of 19 11) Daum Communications Corp ( KQ, W80,100, OUTPERFORM, TP W99,000) ( KS, W201,000, OUTPERFORM [V], TP W330,000) Neowiz Games Corp ( KQ, W43,550, OUTPERFORM [V], TP W75,000) NHN Corp ( KS, W199,500, NEUTRAL, TP W205,000) Disclosure Appendix Important Global Disclosures Jeff Kahng & Jihong Choi each certify, with respect to the companies or securities that he or she analyzes, that (1) the views expressed in this report accurately reflect his or her personal views about all of the subject companies and securities and (2) no part of his or her compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed in this report. See the Companies Mentioned section for full company names. 3-Year Price, Target Price and Rating Change History Chart for KQ KQ Closing Target Price Price Initiation/ Date (W) (W) Rating Assumption 21-Aug Oct Feb Mar N 31-Jul Oct O N 4-May O 4-Aug W N O N Mar May Jul Sep Nov Mar May Jul Sep Nov Mar May Jul Sep Nov-10 Closing Price Target Price Initiation/Assumption Rating O=Outperform; N=Neutral; U=Underperform; R=Restricted; NR=Not Rated; NC=Not Covered O 3-Year Price, Target Price and Rating Change History Chart for KS KS Closing Target Price Price Initiation/ Date (W) (W) Rating Assumption Feb Oct Feb U 17-Apr May Aug O May W Nov U O Mar May Jul Sep Nov Mar May Jul Sep Nov Mar May Jul Sep Nov-10 Closing Price Target Price Initiation/Assumption Rating O=Outperform; N=Neutral; U=Underperform; R=Restricted; NR=Not Rated; NC=Not Covered ( KS / KS) 10

11 20 uary Year Price, Target Price and Rating Change History Chart for KQ KQ Closing Target Price Price Initiation/ Date (W) (W) Rating Assumption 7-Mar O X 31-Jul Oct Apr N 16-Jul O 2-Nov Mar Apr Nov W 7-Mar O N O Mar May Jul Sep Nov Mar May Jul Sep Nov Mar May Jul Sep Nov-10 Closing Price Target Price Initiation/Assumption Rating O=Outperform; N=Neutral; U=Underperform; R=Restricted; NR=Not Rated; NC=Not Covered 3-Year Price, Target Price and Rating Change History Chart for KS KS Closing Target Price Price Initiation/ Date (W) (W) Rating Assumption 12-Feb Aug Oct Feb Jun N 3-Sep O 24-Nov N W N O N Mar May Jul Sep Nov Mar May Jul Sep Nov Mar May Jul Sep Nov-10 Closing Price Target Price Initiation/Assumption Rating O=Outperform; N=Neutral; U=Underperform; R=Restricted; NR=Not Rated; NC=Not Covered The analyst(s) responsible for preparing this research report received compensation that is based upon various factors including Credit Suisse's total revenues, a portion of which are generated by Credit Suisse's investment banking activities. Analysts stock ratings are defined as follows: Outperform (O): The stock s total return is expected to outperform the relevant benchmark* by at least 10-15% (or more, depending on perceived risk) over the next 12 months. Neutral (N): The stock s total return is expected to be in line with the relevant benchmark* (range of ±10-15%) over the next 12 months. Underperform (U): The stock s total return is expected to underperform the relevant benchmark* by 10-15% or more over the next 12 months. *Relevant benchmark by region: As of 29 th May 2009, Australia, New Zealand, U.S. and Canadian ratings are based on (1) a stock s absolute total return potential to its current share price and (2) the relative attractiveness of a stock s total return potential within an analyst s coverage universe**, with Outperforms representing the most attractive, Neutrals the less attractive, and Underperforms the least attractive investment opportunities. Some U.S. and Canadian ratings may fall outside the absolute total return ranges defined above, depending on market conditions and industry factors. For Latin American, Japanese, and non-japan Asia stocks, ratings are based on a stock s total return relative to the average total return of the relevant country or regional benchmark; for European stocks, ratings are based on a stock s total return relative to the analyst's coverage universe**. For Australian and New Zealand stocks a 22% and a 12% threshold replace the 10-15% level in the Outperform and Underperform stock rating definitions, respectively, subject to analysts perceived risk. The 22% and 12% thresholds replace the % and % levels in the Neutral stock rating definition, respectively, subject to analysts perceived risk. **An analyst's coverage universe consists of all companies covered by the analyst within the relevant sector. Restricted (R): In certain circumstances, Credit Suisse policy and/or applicable law and regulations preclude certain types of communications, including an investment recommendation, during the course of Credit Suisse's engagement in an investment banking transaction and in certain other circumstances. Volatility Indicator [V]: A stock is defined as volatile if the stock price has moved up or down by 20% or more in a month in at least 8 of the past 24 months or the analyst expects significant volatility going forward. Analysts coverage universe weightings are distinct from analysts stock ratings and are based on the expected performance of an analyst s coverage universe* versus the relevant broad market benchmark**: Overweight: Industry expected to outperform the relevant broad market benchmark over the next 12 months. Market Weight: Industry expected to perform in-line with the relevant broad market benchmark over the next 12 months. Underweight: Industry expected to underperform the relevant broad market benchmark over the next 12 months. ( KS / KS) 11

12 20 uary 2011 *An analyst s coverage universe consists of all companies covered by the analyst within the relevant sector. **The broad market benchmark is based on the expected return of the local market index (e.g., the S&P 500 in the U.S.) over the next 12 months. Credit Suisse s distribution of stock ratings (and banking clients) is: Global Ratings Distribution Outperform/Buy* 45% (61% banking clients) Neutral/Hold* 42% (60% banking clients) Underperform/Sell* 11% (53% banking clients) Restricted 2% *For purposes of the NYSE and NASD ratings distribution disclosure requirements, our stock ratings of Outperform, Neutral, and Underperform most closely correspond to Buy, Hold, and Sell, respectively; however, the meanings are not the same, as our stock ratings are determined on a relative basis. (Please refer to definitions above.) An investor's decision to buy or sell a security should be based on investment objectives, current holdings, and other individual factors. Credit Suisse s policy is to update research reports as it deems appropriate, based on developments with the subject company, the sector or the market that may have a material impact on the research views or opinions stated herein. Credit Suisse's policy is only to publish investment research that is impartial, independent, clear, fair and not misleading. For more detail please refer to Credit Suisse's Policies for Managing Conflicts of Interest in connection with Investment Research: Credit Suisse does not provide any tax advice. Any statement herein regarding any US federal tax is not intended or written to be used, and cannot be used, by any taxpayer for the purposes of avoiding any penalties. See the Companies Mentioned section for full company names. Price Target: (12 months) for ( KQ) Method: Our target price of W99,000 per share for Daum Communications is based on 11E PE of 15.0x (10% discount to NHN's target PE multiple of 17x). Based on the latest target price, the counter trades at a E P/E (price to earnings ratio) of 14.8x and 11.9x, with three year normalised EPS (earnings per share) CAGR (compound annual growth rate) ( E) of 49%. Risks: The following risks could impede achievement of our target price of W99,000 for Daum Communications: 1) Any unforeseen regulatory action from the government on major Internet portals, 2) sudden slowdown in macro economy, and 3) Direct competition posed by peer NHN in terms of operations. Price Target: (12 months) for ( KS) Method: Our W330,000 target price for NCsoft is based on a target 2012E PE of 18x, at par with other Korean Interent/game peers. Risks: The following risks could impede achievement of our W330,000 target price for NCsoft: 1) significant delay in scheduled game pipeline, 2) failure of game launch in overseas market and 3) potentiall regulation in online game sector. Price Target: (12 months) for ( KQ) Method: Our W75,000 target price for Neowiz Games is based on target 11E PE of 15x. Risks: Potential risks to our W75,000 target price for Neowiz Games include: 1) possible failure of new games launch, 2) potential loss of market share in the web board game segment due to strong competition, and 3) break-up of its alliance with EA. Price Target: (12 months) for ( KS) Method: Our target price of W205,000 for NHN is derived using a 2011E target price to earnings of 18x. Our target price is supported by a discounted cash flow (DCF) based sum-of-the-parts valuation, which values the company at W180,370 per share, based on a 10.5% WACC (weighted average cost of capital) and a 5% perpetual growth rate. Risks: The following risks could impede achievement of our W205,000 target price for NHN: 1) regulation on game revenue, 2) any failure in overseas operations, and 3) the emergence of new search services in the market. Please refer to the firm's disclosure website at for the definitions of abbreviations typically used in the target price method and risk sections. See the Companies Mentioned section for full company names. Credit Suisse expects to receive or intends to seek investment banking related compensation from the subject company ( KS, KQ, KQ) within the next 3 months. As of the end of the preceding month, Credit Suisse beneficially owned 1% or more of a class of common equity securities of ( KS). This holding is calculated according to U.S. regulatory requirements which are based on Section 13(d) of the Securities and Exchange Act of Important Regional Disclosures Singapore recipients should contact a Singapore financial adviser for any matters arising from this research report. The analyst(s) involved in the preparation of this report have not visited the material operations of the subject company ( KQ, KS, KQ, KS) within the past 12 months. Restrictions on certain Canadian securities are indicated by the following abbreviations: NVS--Non-Voting shares; RVS--Restricted Voting Shares; SVS--Subordinate Voting Shares. Individuals receiving this report from a Canadian investment dealer that is not affiliated with Credit Suisse should be advised that this report may not contain regulatory disclosures the non-affiliated Canadian investment dealer would be required to make if this were its own report. For Credit Suisse Securities (Canada), Inc.'s policies and procedures regarding the dissemination of equity research, please visit As of the date of this report, Credit Suisse acts as a market maker or liquidity provider in the equities securities that are the subject of this report. ( KS / KS) 12

13 20 uary 2011 Principal is not guaranteed in the case of equities because equity prices are variable. Commission is the commission rate or the amount agreed with a customer when setting up an account or at anytime after that. To the extent this is a report authored in whole or in part by a non-u.s. analyst and is made available in the U.S., the following are important disclosures regarding any non-u.s. analyst contributors: The non-u.s. research analysts listed below (if any) are not registered/qualified as research analysts with FINRA. The non-u.s. research analysts listed below may not be associated persons of CSSU and therefore may not be subject to the NASD Rule 2711 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. Jeff Kahng, non-u.s. analyst, is a research analyst employed by Credit Suisse Securities (Europe) Limited, Seoul Branch. Jihong Choi, non-u.s. analyst, is a research analyst employed by Credit Suisse Securities (Europe) Limited, Seoul Branch. For Credit Suisse disclosure information on other companies mentioned in this report, please visit the website at or call +1 (877) Disclaimers continue on next page. ( KS / KS) 13

14 20 uary 2011 Asia Pacific/South Korea Equity Research This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject Credit Suisse AG, the Swiss bank, or its subsidiaries or its affiliates ( CS ) to any registration or licensing requirement within such jurisdiction. All material presented in this report, unless specifically indicated otherwise, is under copyright to CS. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of CS. All trademarks, service marks and logos used in this report are trademarks or service marks or registered trademarks or service marks of CS or its affiliates. The information, tools and material presented in this report are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities or other financial instruments. CS may not have taken any steps to ensure that the securities referred to in this report are suitable for any particular investor. CS will not treat recipients as its customers by virtue of their receiving the report. The investments or services contained or referred to in this report may not be suitable for you and it is recommended that you consult an independent investment advisor if you are in doubt about such investments or investment services. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise constitutes a personal recommendation to you. CS does not offer advice on the tax consequences of investment and you are advised to contact an independent tax adviser. Please note in particular that the bases and levels of taxation may change. CS believes the information and opinions in the Disclosure Appendix of this report are accurate and complete. Information and opinions presented in the other sections of the report were obtained or derived from sources CS believes are reliable, but CS makes no representations as to their accuracy or completeness. Additional information is available upon request. CS accepts no liability for loss arising from the use of the material presented in this report, except that this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations applicable to CS. This report is not to be relied upon in substitution for the exercise of independent judgment. CS may have issued, and may in the future issue, a trading call regarding this security. Trading calls are short term trading opportunities based on market events and catalysts, while stock ratings reflect investment recommendations based on expected total return over a 12-month period as defined in the disclosure section. Because trading calls and stock ratings reflect different assumptions and analytical methods, trading calls may differ directionally from the stock rating. In addition, CS may have issued, and may in the future issue, other reports that are inconsistent with, and reach different conclusions from, the information presented in this report. Those reports reflect the different assumptions, views and analytical methods of the analysts who prepared them and CS is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report. CS is involved in many businesses that relate to companies mentioned in this report. These businesses include specialized trading, risk arbitrage, market making, and other proprietary trading. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a judgement at its original date of publication by CS and are subject to change without notice. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities or financial instruments. Investors in securities such as ADR s, the values of which are influenced by currency volatility, effectively assume this risk. Structured securities are complex instruments, typically involve a high degree of risk and are intended for sale only to sophisticated investors who are capable of understanding and assuming the risks involved. The market value of any structured security may be affected by changes in economic, financial and political factors (including, but not limited to, spot and forward interest and exchange rates), time to maturity, market conditions and volatility, and the credit quality of any issuer or reference issuer. Any investor interested in purchasing a structured product should conduct their own investigation and analysis of the product and consult with their own professional advisers as to the risks involved in making such a purchase. Some investments discussed in this report have a high level of volatility. High volatility investments may experience sudden and large falls in their value causing losses when that investment is realised. Those losses may equal your original investment. Indeed, in the case of some investments the potential losses may exceed the amount of initial investment, in such circumstances you may be required to pay more money to support those losses. Income yields from investments may fluctuate and, in consequence, initial capital paid to make the investment may be used as part of that income yield. Some investments may not be readily realisable and it may be difficult to sell or realise those investments, similarly it may prove difficult for you to obtain reliable information about the value, or risks, to which such an investment is exposed. This report may provide the addresses of, or contain hyperlinks to, websites. Except to the extent to which the report refers to website material of CS, CS has not reviewed the linked site and takes no responsibility for the content contained therein. Such address or hyperlink (including addresses or hyperlinks to CS s own website material) is provided solely for your convenience and information and the content of the linked site does not in any way form part of this document. Accessing such website or following such link through this report or CS s website shall be at your own risk. This report is issued and distributed in Europe (except Switzerland) by Credit Suisse Securities (Europe) Limited, One Cabot Square, London E14 4QJ, England, which is regulated in the United Kingdom by The Financial Services Authority ( FSA ). This report is being distributed in Germany by Credit Suisse Securities (Europe) Limited Niederlassung Frankfurt am Main regulated by the Bundesanstalt fuer Finanzdienstleistungsaufsicht ("BaFin"). This report is being distributed in the United States by Credit Suisse Securities (USA) LLC ; in Switzerland by Credit Suisse AG; in Canada by Credit Suisse Securities (Canada), Inc.; in Brazil by Banco de Investimentos Credit Suisse (Brasil) S.A. or its affiliates; in Mexico by Banco Credit Suisse (México), S.A. (transactions related to the securities mentioned in this report will only be effected in compliance with applicable regulation); in Japan by Credit Suisse Securities (Japan) Limited, Financial Instrument Firm, Director-General of Kanto Local Finance Bureau (Kinsho) No. 66, a member of Japan Securities Dealers Association, The Financial Futures Association of Japan, Japan Securities Investment Advisers Association; elsewhere in Asia/Pacific by whichever of the following is the appropriately authorised entity in the relevant jurisdiction: Credit Suisse (Hong Kong) Limited, Credit Suisse Equities (Australia) Limited, Credit Suisse Securities (Thailand) Limited, Credit Suisse Securities (Malaysia) Sdn Bhd, Credit Suisse AG, Singapore Branch, Credit Suisse Securities (India) Private Limited, Credit Suisse Securities (Europe) Limited, Seoul Branch, Credit Suisse AG, Taipei Securities Branch, PT Credit Suisse Securities Indonesia, and elsewhere in the world by the relevant authorised affiliate of the above. Research on Taiwanese securities produced by Credit Suisse AG, Taipei Securities Branch has been prepared by a registered Senior Business Person. Research provided to residents of Malaysia is authorised by the Head of Research for Credit Suisse Securities (Malaysia) Sdn. Bhd., to whom they should direct any queries on In jurisdictions where CS is not already registered or licensed to trade in securities, transactions will only be effected in accordance with applicable securities legislation, which will vary from jurisdiction to jurisdiction and may require that the trade be made in accordance with applicable exemptions from registration or licensing requirements. Non-U.S. customers wishing to effect a transaction should contact a CS entity in their local jurisdiction unless governing law permits otherwise. U.S. customers wishing to effect a transaction should do so only by contacting a representative at Credit Suisse Securities (USA) LLC in the U.S. Please note that this report was originally prepared and issued by CS for distribution to their market professional and institutional investor customers. Recipients who are not market professional or institutional investor customers of CS should seek the advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. This research may relate to investments or services of a person outside of the UK or to other matters which are not regulated by the FSA or in respect of which the protections of the FSA for private customers and/or the UK compensation scheme may not be available, and further details as to where this may be the case are available upon request in respect of this report. Any Nielsen Media Research material contained in this report represents Nielsen Media Research's estimates and does not represent facts. NMR has neither reviewed nor approved this report and/or any of the statements made herein. If this report is being distributed by a financial institution other than Credit Suisse AG, or its affiliates, that financial institution is solely responsible for distribution. Clients of that institution should contact that institution to effect a transaction in the securities mentioned in this report or require further information. This report does not constitute investment advice by Credit Suisse to the clients of the distributing financial institution, and neither Credit Suisse AG, its affiliates, and their respective officers, directors and employees accept any liability whatsoever for any direct or consequential loss arising from their use of this report or its content. Copyright 2011 CREDIT SUISSE AG and/or its affiliates. All rights reserved. CREDIT SUISSE (Hong Kong) Limited Asia/Pacific: TC1482.doc

Asia Equity Strategy Research Analysts Sakthi Siva

Asia Equity Strategy Research Analysts Sakthi Siva Asia Pacific Equity Research Investment Strategy Asia Equity Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com

More information

Asia Equity Strategy Research Analysts Sakthi Siva

Asia Equity Strategy Research Analysts Sakthi Siva Asia Pacific Equity Research Investment Strategy Asia Equity Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com

More information

Japan Focus List. Adding Murata Mfg. Figure 1: Japan Focus List stocks. Name Code Rating. Mitsubishi Chemical Holdings (7/13/2010)

Japan Focus List. Adding Murata Mfg. Figure 1: Japan Focus List stocks. Name Code Rating. Mitsubishi Chemical Holdings (7/13/2010) Asia Pacific/Japan Equity Research Investment Strategy Research Analysts Kenji Kagiya 81 4550 904 kenji.kagiya@credit-suisse.com Japan Focus List THEME Adding Murata Mfg Adding Murata Mfg: We add Murata

More information

NHN Corp ( KS / KS)

NHN Corp ( KS / KS) Asia Pacific/South Korea Equity Research Consumer Internet (Internet) / OVERWEIGHT Rating OUTPERFORM* Price (1 May 12, W) 245, Target price (W) 28,¹ Upside/downside (%) 14.3 Mkt cap (W bn) 11,835.7 (US$

More information

Staples, Inc. (SPLS)

Staples, Inc. (SPLS) Americas/United States Equity Research Specialty Hardlines Rating OUTPERFORM* Price (24 Sep 12, US$) 12.35 Target price (US$) 15.00¹ 52-week price range 16.84-10.66 Market cap. (US$ m) 8,427.33 Enterprise

More information

IASB Improves Pension Accounting

IASB Improves Pension Accounting Americas/United States Equity Research Accounting & Tax Research Analysts David Zion, CFA, CPA 212 538 4837 david.zion@credit-suisse.com Amit Varshney, CFA, FRM 212 538 8049 amit.varshney@credit-suisse.com

More information

1,200 1, Jan-06

1,200 1, Jan-06 Korea Steel Sector------------------------------------------------------------ Maintain OVERWEIGHT Set to expand steelmaking margins Minseok Sinn / Research Analyst / 822 3707 8898 / minseok.sinn@credit-suisse.com

More information

Canadian Natural Resources

Canadian Natural Resources Americas/Canada Equity Research Oil & Gas Exploration & Production Canadian Natural Resources Rating OUTPERFORM* Price (18 Mar 13, C$) 33.31 Target price (C$) 45.00¹ 52-week price range 35.50-25.84 Market

More information

DISCLOSURE APPENDIX CONTAINS ANALYST CERTIFICATIONS AND THE STATUS OF NON-US ANALYSTS. FOR OTHER IMPORTANT DISCLOSURES,

DISCLOSURE APPENDIX CONTAINS ANALYST CERTIFICATIONS AND THE STATUS OF NON-US ANALYSTS. FOR OTHER IMPORTANT DISCLOSURES, Asia Pacific Equity Research Investment Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com GEM Equity Strategy

More information

Nomura Holdings (8604 / 8604 JP)

Nomura Holdings (8604 / 8604 JP) Asia Pacific/Japan Equity Research Brokerage (Brokerage & Asset Managers) / OVERWEIGHT Rating OUTPERFORM [V] Price (25 Jul 12, ) 245 Target price ( ) 320¹ Chg to TP (%) 30.6 Market cap. ( bn) 897.55 (US$

More information

Eli Lilly & Co (LLY)

Eli Lilly & Co (LLY) Americas/United States Equity Research Major Pharmaceuticals Research Analysts Credit Suisse US Eq. Res 877 291 2683 equity.research@credit-suisse.com Eli Lilly & Co (LLY) FOCUS LIST Adding to the Focus

More information

Shinhan Financial Group

Shinhan Financial Group Asia Pacific/South Korea Equity Research Regional Banks (Banks) / OVERWEIGHT Rating OUTPERFORM* Price (31 Jul 12, W) 36,200 Target price (W) (from 55,000) 50,000¹ Upside/downside (%) 38.1 Mkt cap (W bn)

More information

Eastern Platinum Ltd (ELR.TO)

Eastern Platinum Ltd (ELR.TO) Americas/Canada Equity Research Precious Metals Rating OUTPERFORM* [V] Price (29 May 12, C$) 0.28 Target price (C$) 0.65¹ 52-week price range 1.03-0.24 Market cap. (C$ m) 259.89 Enterprise value (US$ m)

More information

Walmex (WALMEXV) July SSS below consensus. Remaining on the sidelines CREDIT SUISSE SECURITIES RESEARCH & ANALYTICS

Walmex (WALMEXV) July SSS below consensus. Remaining on the sidelines CREDIT SUISSE SECURITIES RESEARCH & ANALYTICS Americas/Mexico Equity Research General Merchandise Stores Rating NEUTRAL* Price (07 Aug 12, MXN) 39.06 Target price (MXN) 38.00¹ 52-week price range 44.87-29.42 Market cap. (MXN m) 693,178.77 Enterprise

More information

Figure 1: Earnings forecast summary

Figure 1: Earnings forecast summary Asia Pacific/Japan Equity Research Technology (Electric Components (Japan)) / MARKET WEIGHT Rating OUTPERFORM* Price (05 Dec 12, ) 4,600 Target price ( ) (from 4,300) 5,500¹ Chg to TP (%) 19.6 Market cap.

More information

Kinross Gold Corp.: First Read

Kinross Gold Corp.: First Read Americas/Canada&United States Equity Research Precious Metals Kinross Gold Corp.: First Read Rating NEUTRAL* Price (08 Aug 12, US$) 7.83 Target price (US$) (from 10.00) 9.50¹ 52-week price range 18.18-7.31

More information

Mitsubishi Chemical Holdings

Mitsubishi Chemical Holdings Asia Pacific/Japan Equity Research Major Chemicals (Chemicals/Textiles) / MARKET WEIGHT Mitsubishi Chemical Holdings Rating (from Outperform) NEUTRAL* Price (29 Aug 12, ) 315 Target price ( ) (from 470)

More information

Holcim Indonesia (SMCB.JK / SMCB IJ) Running at full capacity

Holcim Indonesia (SMCB.JK / SMCB IJ) Running at full capacity Asia Pacific/Indonesia Equity Research Cement Rating NEUTRAL* Price (28 Mar 12, Rp) 2,575.00 Target price (Rp) (from 2,400.00) 2,800.00¹ Chg to TP (%) 8.7 Market cap. (Rp bn) 19,732 Enterprise value (Rp

More information

800, , , , , , , ,000

800, , , , , , , ,000 2005 2006 2007 2008 2009 2010 2011 02 January 2013 China Merchant Holdings ---------------------------------------------------------Maintain NEUTRAL A new acquisition in Djibouti, the entrance of the Red

More information

Genting Berhad (GENT.KL / GENT MK) 1Q11 EBITDA up 74% YoY

Genting Berhad (GENT.KL / GENT MK) 1Q11 EBITDA up 74% YoY Asia Pacific/Malaysia Equity Research Casinos & Gaming Rating OUTPERFORM* Price (25 May 11, RM) 10.94 Target price (RM) 13.60¹ Chg to TP (%) 24.3 Market cap. (RM mn) 40,627.3 Enterprise value (RM mn) 41,410

More information

Bulgari (BULG.MI) Feedback from Basel presentation. 09 April 2008 Europe/Italy Equity Research Luxury Goods / OVERWEIGHT

Bulgari (BULG.MI) Feedback from Basel presentation. 09 April 2008 Europe/Italy Equity Research Luxury Goods / OVERWEIGHT Europe/Italy Equity Research Luxury Goods / OVERWEIGHT Rating NEUTRAL* Price (08 Apr 08, Eu) 7.24 Target Price (Eu) 8.50¹ Market cap. (Eu m) 2,159.45 Enterprise value (Eu m) 2,309.6 *Stock ratings are

More information

Tata Consultancy Services

Tata Consultancy Services Asia Pacific/India Equity Research Computer Services & IT Consulting (IT Services) / OVERWEIGHT Rating (from Outperform) NEUTRAL* Price (22 Apr 11, Rs) 1,191.65 Target price (Rs) (from 1,325.00) 1,275.00¹

More information

Sunoco Logistics Partners, LP

Sunoco Logistics Partners, LP Americas/United States Equity Research Master Limited Partnerships Sunoco Logistics Partners, LP Rating NEUTRAL* Price (03 Jan 14, US$) 73.20 Target price (US$) (from 72.00) 81.00¹ 52-week price range

More information

Container Manufacturing Sector

Container Manufacturing Sector Asia Pacific/China Equity Research Industrial Machinery (Transportation) Research Analysts Ingrid Wei 86 21 3856 379 ingrid.wei@credit-suisse.com Sam Lee 852 211 7186 sam.lee@credit-suisse.com Container

More information

Nippon Telegraph and Telephone (9432 / 9432 JP)

Nippon Telegraph and Telephone (9432 / 9432 JP) 05 August 2015 Asia Pacific/Japan Equity Research Integrated Telecommunication Services (Telecommunication Services (Japan)) / OVERWEIGHT Rating OUTPERFORM Price (05 Aug 15, ) 4,794 Target price ( ) 5,000¹

More information

Li & Fung (0494.HK / 494 HK) COMPANY UPDATE

Li & Fung (0494.HK / 494 HK) COMPANY UPDATE Asia Pacific/Hong Kong Equity Research Distributors Rating UNDERPERFORM* [V] Price (15 Nov 12, HK$) 12.66 Target price (HK$) 1.4¹ Upside/downside (%) -17.9 Mkt cap (HK$ mn) 15,87 (US$ 13,651) Enterprise

More information

Market Spotlight/Trade Idea: 30yr US TIPS Breakevens

Market Spotlight/Trade Idea: 30yr US TIPS Breakevens 02 June 2011 Fixed Income Research http://www.credit-suisse.com/researchandanalytics Market Spotlight/Trade Idea: 30yr US TIPS Breakevens Global Strategy Technical Analysis 30yr US TIPS Breakevens Inflation

More information

Sony (6758 / 6758 JP)

Sony (6758 / 6758 JP) Asia Pacific/Japan Equity Research Consumer Electronics (Electrical Equipment (Japan)) / MARKET WEIGHT Rating OUTPERFORM Price (04 Feb 15, ) 2,769 Target price ( ) 3,300¹ Chg to TP (%) 19.2 Market cap.

More information

Fubon Financial Holding

Fubon Financial Holding Asia Pacific/Taiwan Equity Research Multi Line Insurance (Insurance) Rating (from Neutral) OUTPERFORM* Price (10 Aug 12, NT$) 30.60 Target price (NT$) (from 32.38) 38.00¹ Upside/downside (%) 24.2 Mkt cap

More information

Toho Titanium (5727 / 5727 JP)

Toho Titanium (5727 / 5727 JP) Asia Pacific/Japan Equity Research Diversified Metals & Mining (Titanium (Japan)) / OVERWEIGHT Rating OUTPERFORM* Price (08 Dec 14, ) 779 Target price ( ) (from 900) 930¹ Chg to TP (%) 19.4 Market cap.

More information

Li & Fung (0494.HK / 494 HK)

Li & Fung (0494.HK / 494 HK) 22 June 211 Asia Pacific/Hong Kong Equity Research Distributors Rating OUTPERFORM* Price (21 Jun 11, HK$) 15.58 Target price (HK$) (from 25.5) 19.2¹ Chg to TP (%) 23.2 Market cap. (HK$ mn) 126,183.6 Enterprise

More information

QBE Insurance Group (QBE.AX / QBE AU)

QBE Insurance Group (QBE.AX / QBE AU) Asia Pacific/Australia Equity Research Property & Casualty Insurance (Insurance (AU)) Rating NEUTRAL* Price (07 Apr 15, A$) 13.67 Target price (A$) 13.40¹ Market cap. (A$mn) 18,658.80 Yr avg. mthly trading

More information

Tokyo Electron (8035 / 8035 JP)

Tokyo Electron (8035 / 8035 JP) Asia Pacific/Japan Equity Research Semiconductor Equipment (Semiconductor Devices (Japan)) / MARKET WEIGHT Rating OUTPERFORM Price (08 Jul 14, ) 7,200 Target price ( ) 6,150¹ Chg to TP (%) -14.6 Market

More information

12,500 10,000 7,500 5,000 2,500 2,000. Net profit (Rmb mn) 1,500 1,000

12,500 10,000 7,500 5,000 2,500 2,000. Net profit (Rmb mn) 1,500 1,000 Avg ADT / Margin finance balance (Rmb bn) Net profit (Rmb mn) Net profit (Rmb mn) % difference 10 August 2015 China Brokers Sector (H) --------------------------------------------------- Maintain OVERWEIGHT

More information

Keeping Score; Weekly Railroad Update

Keeping Score; Weekly Railroad Update Americas/United States Equity Research Railroads / MARKET WEIGHT Research Analysts Christopher J. Ceraso, CFA 2 538 4529 chris.ceraso@credit-suisse.com Allison M. Landry 2 325 37 allison.landry@credit-suisse.com

More information

NGK Insulators (5333 / 5333 JP)

NGK Insulators (5333 / 5333 JP) 3 December 21 Asia Pacific/Japan Equity Research Glass and Ceramics / OVERWEIGHT Rating (from Neutral) OUTPERFORM* Price (2 Dec 1, ) 1,292 Target price ( ) (from 1,35) 1,5¹ Chg to TP (%) 16.1 Market cap.

More information

Keeping Score; Weekly Railroad Update

Keeping Score; Weekly Railroad Update Americas/United States Equity Research Railroads / MARKET WEIGHT Research Analysts Christopher J. Ceraso, CFA 2 538 4529 chris.ceraso@credit-suisse.com Allison M. Landry 2 325 37 allison.landry@credit-suisse.com

More information

Precious metal prices stronger for longer. Precious metal prices stronger for longer

Precious metal prices stronger for longer. Precious metal prices stronger for longer Dr +27 11 384 214 david.davis@csss-sa.com Source: CSSS November 27 IMPORTANT DISCLOSURES AND ANALYST CERTIFICATIONS ARE IN THE DISCLOSURE APPENDIX. 1 In this debate we define precious metals as gold, platinum

More information

21 September 2012 Asian Daily

21 September 2012 Asian Daily Tiger Airways -------------------------------------------------------------- Maintain UNDERPERFORM Meeting with the new CEO EPS: TP: Annuar Aziz / Research Analyst / 603 2723 2084 / annuar.aziz@credit-suisse.com

More information

Samsung Electronics ( KS /

Samsung Electronics ( KS / Asia Pacific/South Korea Equity Research Semiconductor Devices Rating OUTPERFORM Price (28 Nov 16, W) 1,677,000 Target price (W) 1,790,000 Upside/downside (%) 6.7 Mkt cap (W/US$ bn) 235,919 / 201.87 Enterprise

More information

Melco Crown Entertainment ADR (MPEL.OQ / MPEL US)

Melco Crown Entertainment ADR (MPEL.OQ / MPEL US) Asia Pacific/Hong Kong Equity Research Casinos & Gaming Rating OUTPERFORM* [V] Price (15 Jun 11, US$) 10.95 Target price (US$) (from 14.60) 16.00¹ Chg to TP (%) 46.1 Market cap. (US$ mn) 5,860.7 Enterprise

More information

100% 90% 80% 70% 60% 50% 40% 30% 20% 10% Up/dn to TP

100% 90% 80% 70% 60% 50% 40% 30% 20% 10% Up/dn to TP Hangzhou Hikvision Digital Technology Co., Ltd. ---------------- Maintain OUTPERFORM Revise down estimates on macro but thesis unchanged EPS: TP: Sam Li / Research Analyst / 852 2101 6775 / sam.li@credit-suisse.com

More information

LG Household & Healthcare

LG Household & Healthcare Asia Pacific/South Korea Equity Research Personal Products Rating OUTPERFORM* Price (27 Jan 15, W) 626,000 Target price (W) 720,000¹ Upside/downside (%) 15.0 Mkt cap 9,777.0 (US$ 9.0) Enterprise value

More information

Paper & Packaging. WestRock hikes containerboard prices $50/t. 15 February 2017 Americas/United States Equity Research Paper Products

Paper & Packaging. WestRock hikes containerboard prices $50/t. 15 February 2017 Americas/United States Equity Research Paper Products Americas/United States Equity Research Paper Products Research Analysts Lars Kjellberg 46 8 5450 7926 lars.kjellberg@credit-suisse.com Specialist Sales: James Brady 44 20 7888 4267 james.brady@credit-suisse.com

More information

DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, AND THE STATUS OF NON-US ANALYSTS.

DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, AND THE STATUS OF NON-US ANALYSTS. Japanese Shipping Sector ------------------------------------------------- Maintain OVERWEIGHT Quantifying potential price fixing fines Davin Wu / Research Analyst / 852 2101 6917 / davin.wu@credit-suisse.com

More information

Home Depot (HD) FORECAST REDUCTION. A New Dawn

Home Depot (HD) FORECAST REDUCTION. A New Dawn Americas/United States Equity Research Specialty Hardlines (Hardlines Retail) / UNDERWEIGHT Rating NEUTRAL* Price (12 Jan 07) 40.11 (US$) Target price (12M) 37.00 (US$) 52 week high - low 43.81-33.13 Market

More information

Russian Steel & Bulks

Russian Steel & Bulks EEMEA/Russia Equity Research Steel Research Analysts Semyon Mironov 7 495 662 8510 semyon.mironov@credit-suisse.com Dmitry Glushakov, CFA 7 495 662 8512 dmitry.glushakov@credit-suisse.com Russian Steel

More information

Asia Pacific Equity Strategy

Asia Pacific Equity Strategy Asia Pacific Equity Research Investment Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com Asia Pacific Equity

More information

Asia Pacific Equity Strategy

Asia Pacific Equity Strategy Asia Pacific Equity Research Investment Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com Asia Pacific Equity

More information

William Lyon Homes (WLH)

William Lyon Homes (WLH) Americas/United States Equity Research Homebuilding Rating OUTPERFORM* [V] Price (14 Feb 14, US$) 28.95 Target price (US$) 28.00¹ 52-week price range 28.95-18.94 Market cap. (US$ m) 910.21 Enterprise value

More information

P/B (x) rating) Local Target (%) (%) T T+1 T+2 T+1 T+2 T+1 T+2 T+1 T+2 T+1 T+1 T+1 GCL-Poly 3800.HK O (O) [V]

P/B (x) rating) Local Target (%) (%) T T+1 T+2 T+1 T+2 T+1 T+2 T+1 T+2 T+1 T+1 T+1 GCL-Poly 3800.HK O (O) [V] GCL-Poly Energy Holdings Limited ------------------------------------- Maintain OUTPERFORM FY14 result in line; cost leadership intact; maintain OUTPERFORM rating and TP EPS: TP: Baiding Rong / Research

More information

Linde (LING.F) Getting big in the US, but at what price? CREDIT SUISSE SECURITIES RESEARCH & ANALYTICS

Linde (LING.F) Getting big in the US, but at what price? CREDIT SUISSE SECURITIES RESEARCH & ANALYTICS Europe/Germany Equity Research Industrial Gases (Chemicals) Rating (from Outperform) NEUTRAL* Price (02 Jul 12, Eu) 120.78 Target price (Eu) (from 148.00) 135.00¹ Market cap. (Eu m) 20,785.82 Enterprise

More information

Suntec REIT (SUNT.SI / SUN SP) Source: Company data, Thomson Reuters, Credit Suisse estimates.

Suntec REIT (SUNT.SI / SUN SP) Source: Company data, Thomson Reuters, Credit Suisse estimates. Asia Pacific/Singapore Equity Research REITs Rating UNDERPERFORM* Price (31 Oct 11, S$) 1.24 Target price (S$) 1.10¹ Chg to TP (%) -11.3 Market cap. (S$ mn) 2,751 Enterprise value (S$ mn) 5,366 Number

More information

Woodward Inc (WWD) SMALL & MID CAP RESEARCH. Source: Company data, Credit Suisse estimates

Woodward Inc (WWD) SMALL & MID CAP RESEARCH. Source: Company data, Credit Suisse estimates Americas/United States Equity Research Aerospace & Defense Woodward Inc (WWD) SMALL & MID CAP RESEARCH Bolstering Supplier Relationship with GE JV Estimate revisions: Our FY'15 EPS estimate is unchanged,

More information

10,000 8,000 6,000 4,000 2,000 40% 20% -20% -40% -60%

10,000 8,000 6,000 4,000 2,000 40% 20% -20% -40% -60% Agile Property ----------------------------------------------------------------------- Maintain NEUTRAL Notes from the CIC: Investors like margin recovery but do not like gearing deterioration EPS: TP:

More information

Drake & Scull International PJSC (DSI.DU)

Drake & Scull International PJSC (DSI.DU) EEMEA/United Arab Emirates Equity Research Engineering & Construction (Emerging EMEA) Rating OUTPERFORM* Price (07 Feb 11, Dhs) 1.08 Target Price (Dhs) (from 1.22) 1.30¹ Market cap. (Dhs m) 2,317.01 Enterprise

More information

Dry Bulk Sector Outlook

Dry Bulk Sector Outlook Americas/United States Equity Research Dry Bulk Sector Outlook SMALL & MID CAP RESEARCH Dusting Off Our Drybulk Playbook - We Note We Expect It To Get Worse Before Better Exhibit 1: Drybulk Carrier Taking

More information

Coway ( KS) Good start to China water-purifier market entry. Korea Research KRW121,000 KRW103,000. Event. Impact. Action and recommendation

Coway ( KS) Good start to China water-purifier market entry. Korea Research KRW121,000 KRW103,000. Event. Impact. Action and recommendation Korea Research This research report is a product of (Korea) Flashnote Korea / Consumer 1 June 2016 BUY Target price Last price (31 May 2016) KRW121,000 KRW103,000 Upside/downside (%) 17.5 KOSPI 1,983.40

More information

98% 97% 96% 95% 94% 93% 92%

98% 97% 96% 95% 94% 93% 92% Spring REIT --------------------------------------------------------------------------- Maintain NEUTRAL 1H16 started seeing falling yield DPS: TP: Kelvin Tam, CFA / Research Analyst / 852 2101 6582 /

More information

Komatsu (6301 / 6301 JP)

Komatsu (6301 / 6301 JP) Asia Pacific/Japan Equity Research Construction & Farm Machinery (Machinery (Japan)) / MARKET WEIGHT Rating NEUTRAL* Price (22 Jan 14, ) 2,151 Target price ( ) 1,900¹ Chg to TP (%) -11.7 Market cap. (

More information

25 August 2016 Asian Daily

25 August 2016 Asian Daily Joy City ------------------------------------------------------------------------- Maintain OUTPERFORM A possible special dividend to unlock the huge hidden value EPS: TP: Alvin Wong / Research Analyst

More information

Wacker Chemie (WCHG.DE)

Wacker Chemie (WCHG.DE) Europe/Germany Equity Research Specialty Chemicals Rating NEUTRAL Price (26 Oct 16, ) 80.29 Target price ( ) 70.00 Market Cap ( m) 4,187.3 Enterprise value ( m) 8,243.3 *Stock ratings are relative to the

More information

Wealth Report Analysis

Wealth Report Analysis Global Equity Research Luxury Goods Research Analysts Rogerio Fujimori 44 20 7888 0889 rogerio.fujimori@credit-suisse.com Patrick Jnglin, CFA 41 44 334 6077 patrick.jnglin@credit-suisse.com Specialist

More information

TransGlobe Energy Corp. (TGL.TO)

TransGlobe Energy Corp. (TGL.TO) Americas/Canada Equity Research Oil & Gas Exploration & Production Rating NEUTRAL* Price (09 Dec 13, C$) 9.18 Target price (C$) 9.50¹ 52-week price range 9.84-6.01 Market cap. (C$ m) 679.59 Enterprise

More information

Initiation of Coverage

Initiation of Coverage Americas/Brazil Equity Research Education Services (Small Cap (South America)) Research Analysts Clarissa Berman 55 11 3701 6316 clarissa.berman@credit-suisse.com Gustavo Wigman 55 11 3701 6302 gustavo.wigman@credit-suisse.com

More information

Singapore Market Strategy---------------------------------------------------------------------------------- Zika: Lessons from SARS and other pandemics Gerald Wong, CFA / Research Analyst / 65 6212 3037

More information

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK 20 December 20 China Coal Market Decelerating production growth Firm spot coal prices expected in 2006: China s coal production in November only grew by 3.1% Y/Y, highlighting the production disruption

More information

200% 150% 100% 50% -50% 200% 150% 100% 50% -50% -100%

200% 150% 100% 50% -50% 200% 150% 100% 50% -50% -100% China Property Sector ------------------------------------------------- Maintain MARKET WEIGHT Inventory showing improvement Alvin Wong / Research Analyst / 852 2101 6486 / alvin.wong@credit-suisse.com

More information

Magnit (MGNTq.L) INCREASE TARGET PRICE

Magnit (MGNTq.L) INCREASE TARGET PRICE EEMEA/Russia Equity Research Food Retail (Emerging EMEA (Europe)) Rating OUTPERFORM* Price (08 Feb 13, US$) 45.10 Target price (US$) (from 42.00) 55.00¹ Market cap. (US$ m) 22,580.09 Enterprise value (US$

More information

20 June 2016 Asian Daily

20 June 2016 Asian Daily Coolpad Group Limited ------------------------------------------------ Maintain UNDERPERFORM Letv to become largest shareholder; limited help to near-term headwinds EPS: TP: Kyna Wong / Research Analyst

More information

Quantitative Analysis

Quantitative Analysis Global Equity Research Quantitative Analysis Research Analysts Pankaj N. Patel, CFA 212 538 5239 pankaj.patel@credit-suisse.com Souheang Yao 212 538 361 souheang.yao@credit-suisse.com Ryan Carlson 212

More information

07 April 2015 Asian Daily

07 April 2015 Asian Daily Bloomage BioTechnology Corporation Limited ------------------- Maintain OUTPERFORM End product benefits from value chain integration EPS: TP: Iris Wang / Research Analyst / 852 2101 7646 / iris.wang@credit-suisse.com

More information

06 July 2015 Asian Daily

06 July 2015 Asian Daily Megaworld Corp ----------------------------------------------------------------------Maintain NEUTRAL Residential business is showing cracks EPS: TP: Danielo Picache / Research Analyst / 632 858 7758 /

More information

DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, AND THE STATUS OF NON-US ANALYSTS.

DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, AND THE STATUS OF NON-US ANALYSTS. Americas/Canada Equity Research Multinational Banks (Financials (Canada)) Research Analysts Kevin R. Choquette, CFA, CPA, CMA 416-352-4585 kevin.choquette@credit-suisse.com Nick Stogdill, CA, CFA 416 352

More information

Fertilizers WEEKLY ANALYSIS. Weekly fertilizer prices monitor

Fertilizers WEEKLY ANALYSIS. Weekly fertilizer prices monitor Global Equity Research Fertilizers Research Analysts Semyon Mironov 7 495 662 8510 semyon.mironov@credit-suisse.com Mikhail Priklonsky 7 495 662 8511 mikhail.priklonsky@credit-suisse.com Fertilizers WEEKLY

More information

Seadrill (SDRL) FORECAST REDUCTION

Seadrill (SDRL) FORECAST REDUCTION Americas/United States Equity Research Oil & Gas Equipment & Services Rating OUTPERFORM* Price (28 Feb 13, US$) 36.82 Target price (US$) 48.00¹ 52-week price range 42.07-32.07 Market cap. (US$ m) 17,230.64

More information

A penny for a thought and not much more for the investments?

A penny for a thought and not much more for the investments? Mark Samter Research Analyst Mark.Samter@credit-suisse.com; +612 8205 4537 August 2015 DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, AND THE STATUS

More information

Tech Mahindra Limited (TEML.BO / TECHM

Tech Mahindra Limited (TEML.BO / TECHM Asia Pacific/India Equity Research Computer Services & IT Consulting Tech Mahindra Limited (TEML.BO / TECHM Rating OUTPERFORM Price (06-Mar-17, Rs) 499.25 Target price (Rs) 550.00 Upside/downside (%) 10.2

More information

New merchandise to prop up results

New merchandise to prop up results Korea/Pharmaceuticals Daewoong Pharmaceutical Earnings preview BUY 12 July 2010 BUY BUY BUY 4 May 2010 16 Apr 2010 23 Mar 2010 Ji-Won Shin, Korea Pharmaceuticals Analyst, +82 2 3774 2176 jwshin@miraeasset.com

More information

BT Group (BT.L) Ofcom Openreach agreement reached WLA the next regulatory step

BT Group (BT.L) Ofcom Openreach agreement reached WLA the next regulatory step Europe/United Kingdom Equity Research Integrated Telecommunication Services Rating NEUTRAL Price (09 Mar 17, p) 330.20 Target price (p) 400.00 Market Cap ( m) 32,888.5 Enterprise value ( m) 42,794.7 Target

More information

29 September 2015 Asian Daily

29 September 2015 Asian Daily Gamuda ------------------------------------------------------------------------- Maintain OUTPERFORM FY15 results in line; expect positive order flow momentum to drive re-rating EPS: TP: Danny Goh / Research

More information

Sun Pharmaceuticals Industries Limited (SUN.BO / SUNP IN)

Sun Pharmaceuticals Industries Limited (SUN.BO / SUNP IN) Rating NEUTRAL Price (02-Mar-17, Rs) 676.05 Target price (Rs) 620.00 Upside/downside (%) -8.3 Mkt cap (Rs/US$ mn) 1,622,041 / 24,297 Enterprise value (Rs mn) 1,496,683 Number of shares (mn) 2,399 Free

More information

Investment Guarantees Seminar

Investment Guarantees Seminar Equity Research 10 June 2004 Europe Life Insurance Insurance MARKET WEIGHT research team Maurizio Lualdi 44 20 7888 9228 maurizio.lualdi@csfb.com Laurent Rousseau 44 20 7888 0265 laurent.rousseau@csfb.com

More information

100,000 80,000 60,000 40,000 20,000

100,000 80,000 60,000 40,000 20,000 Sinopec Engineering (Group) Co Ltd ----------------------------- Maintain UNDERPERFORM 2015 results in line, remain cautious on outlook EPS: TP: Kelly Chen / Research Analyst / 852 2101 7079 / kelly.chen@credit-suisse.com

More information

Adidas AG (ADSGn.F) 4Q full steam ahead, 3 questions for CMD. 8 March 2017 Europe/Germany Equity Research Luxury Goods

Adidas AG (ADSGn.F) 4Q full steam ahead, 3 questions for CMD. 8 March 2017 Europe/Germany Equity Research Luxury Goods Europe/Germany Equity Research Luxury Goods Rating NEUTRAL Price (07 Mar 17, ) 160.00 Target price ( ) 136.00 Market Cap ( m) 33,474.6 Enterprise value ( m) 33,969.7 Target price is for 12 months. Research

More information

ONUG Conference Review

ONUG Conference Review Americas/United States Equity Research Software (Software (US)) / OVERWEIGHT Research Analysts Philip Winslow, CFA 212 325 6157 philip.winslow@credit-suisse.com Sitikantha Panigrahi 212 325 2686 sitikantha.panigrahi@credit-suisse.com

More information

Swiss Institutional Investors Conference - High Yield Consumer

Swiss Institutional Investors Conference - High Yield Consumer Swiss Institutional Investors Conference - High Yield Consumer June 2009 Ben Booth, Managing Director, European Credit Research +44 20 7888 1721 ben.booth@credit-suisse.com ANALYST CERTIFICATIONS AND IMPORTANT

More information

The Reject Shop (TRS.AX / TRS AU) UPGRADE RATING

The Reject Shop (TRS.AX / TRS AU) UPGRADE RATING Asia Pacific/Australia Equity Research General Merchandise Stores (Consumer retail - SMID (AU)) Rating (from Underperform) NEUTRAL* Price (24 Jan 14, A$) 12.86 Target price (A$) (from 13.70) 13.50¹ Market

More information

OC Oerlikon Corp AG (OERL.S)

OC Oerlikon Corp AG (OERL.S) Europe/Switzerland Equity Research Industrial Machinery OC Oerlikon Corp AG (OERL.S) SMALL & MID CAP RESEARCH CMD on 30 November will be a key event Key Points Oerlikon is a Swiss-based industrial conglomerate

More information

Samsung Engineering ( KS / KS) A scarcity value

Samsung Engineering ( KS / KS) A scarcity value Asia Pacific/South Korea Equity Research Engineering & Construction / MARKET WEIGHT Rating OUTPERFORM* Price (25 Jul 11, W) 270,000 Target price (W) (from 250,000) 300,000¹ Chg to TP 11.1 Market cap (W

More information

ARCA CONTINENTAL (AC*)

ARCA CONTINENTAL (AC*) Americas/Mexico Equity Research Soft Drinks Rating NEUTRAL Price (18-Oct-16,MXN) 119.50 Target price (MXN) 125.00 52-week price range 133.89-98.78 Market cap (MXN m) 200,321.71 Enterprise value (MXN m)

More information

President Trump & global trade slump:

President Trump & global trade slump: President Trump & global trade slump: What they mean for Asia November 2016 Michael Wan, ASEAN Economist michael.wan@credit-suisse.com DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT

More information

Global equity strategy

Global equity strategy Global equity strategy Andrew Garthwaite and team Tactical Indicators for equities Andrew Garthwaite, andrew.garthwaite@credit-suisse.com, +44 20 7883 6477 Luca Paolini, luca.paolini@credit-suisse.com,

More information

FedEx Corporation (FDX)

FedEx Corporation (FDX) Americas/United States Equity Research Air Freight & Couriers Rating OUTPERFORM Price (21-Mar-17, US$) 191.84 Target price (US$) (from 209.00) 219.00 52-week price range (US$) 201.02-146.13 Market cap

More information

Achaogen (AKAO) SMALL & MID CAP RESEARCH

Achaogen (AKAO) SMALL & MID CAP RESEARCH Americas/United States Equity Research Biotechnology Rating OUTPERFORM* [V] Price (11 Aug 14, US$) 10.14 Target price (US$) 22.00¹ 52-week price range 18.95-9.22 Market cap. (US$ m) 179.28 Enterprise value

More information

Tata Motors Ltd. (TAMO.BO)

Tata Motors Ltd. (TAMO.BO) Asia Pacific/India Equity Research Auto Parts & Equipment Rating OUTPERFORM [V] Price (06-Mar-17, Rs) 470.70 Target price (Rs) 630.00 Upside/downside (%) 33.8 Mkt cap (Rs/US$ mn) 1,359,075 / 20,395 Enterprise

More information

View from the market Jahangir Aziz

View from the market Jahangir Aziz S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L View from the market Jahangir Aziz 202-585-1254 jahangir.x.aziz@jpmorgan.com Mar-09 Aug-09 Dec-09 May-10 Oct-10 Mar-11 Aug-11 Jan-12 INR: India

More information

01 March 2016 Asian Daily

01 March 2016 Asian Daily China Medical System Holdings Ltd. ----------------------------------- Maintain OUTPERFORM Acquiring commercialisation rights of two original drugs from AstraZeneca EPS: TP: Iris Wang / Research Analyst

More information

Royal Bank of Canada (RY.TO)

Royal Bank of Canada (RY.TO) Americas/Canada Equity Research Multinational Banks Rating OUTPERFORM Price (23 Feb 16, C$) 69.63 * Target price (C$) 90.00¹ 52-week price range 81.27-65.00 Market cap. (C$ m) 103,509.02 Enterprise value

More information

10 September 2015 Asian Daily

10 September 2015 Asian Daily PRADA S.p.A. ------------------------------------------------------------- Maintain UNDERPERFORM 1H FY16 preview: Margin pressure persists EPS: TP: Isis Wong / Research Analyst / 852 2101 7109 / isis.wong@credit-suisse.com

More information